Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 11.40
+0.14 (1.24%)
Last updated: Nov 3, 2025, 9:42 AM CST
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 25.4 billion as of November 3, 2025. Its market cap has decreased by -16.45% in one year.
Market Cap
25.40B
Enterprise Value
25.91B
Revenue
4.74B
Ranking
n/a
PE Ratio
27.26
Stock Price
11.40
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 25.40B, an increase of 13.70%. That is a compound annual growth rate of 4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 25.42B | -3.75% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 426.22B |
| WuXi AppTec | 294.61B |
| Shenzhen Mindray Bio-Medical Electronics | 260.07B |
| Sichuan Biokin Pharmaceutical | 153.99B |
| Shanghai United Imaging Healthcare | 114.74B |
| Aier Eye Hospital Group | 113.87B |
| Zhangzhou Pientzehuang Pharmaceutical., | 107.47B |
| Yunnan Baiyao Group Co.,Ltd | 101.10B |